Peynircio臒lu B, Hizal M, Cil B, Deuerling-Zheng Y, Von Roden M, Hazirolan T, Akata D, Ozmen M, Balkanci F. Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion. ...
For these reasons, the AFP test is not used to screen the general population for cancer. AFP is not only a tumor marker. Because AFP is produced by the fetus, levels are normally higher in pregnant women and in their newborns. What are the risk factors for liver cancer? This cancer ...
Click on the tumor marker to go to the test article for more details on a particular marker. Tumor markerAssociated cancer(s)Usual sampleUse(s)Comments AFP (Alpha-feto protein) Certain liver, ovarian, testicular Blood Helps diagnose, monitors treatment and for recurrence Also elevated during ...
To date, there have not been great breakthroughs in immunotherapy for HER2 positive breast cancer (HPBC). This study aimed to build a risk model that might contribute to predicting prognosis and discriminating the immune landscape in patients with HPBC.
s Day of 1987 I started bleeding under the skin. My husband made circles around the outside perimeter each hour with a marker, like the rings of a tree. When I went to my Internist the next day he was shocked at the size. He now thought I had a blood disorder so he sent me to...
To test whether tumor organoids may be used to obtain tumor reactive T cells, we selected MHC class I proficient tumor organoids and focused on the peripheral blood compartment as a source of T cells with a lower degree of exhaustion. Prior to co-culture with autologous T cells, tumor orga...
HER2-XPAT protein and unmasked HER2-TCE promoted similar T-cell activation in the tumor microenvironment (TME), indicated by increased expression of activation marker CD25 on both helper and cytotoxic T cells (Fig. 3c). T cells were not activated in peripheral blood where human HER2 is not ...
Of note, all successfully transplanted organoids gave rise to xenograft tumors that recapitulated the histopathological features and the tumor marker expression (Figure 4B) of the originating organoids and the original tumors. In contrast, and as expected, none of the paired non-tumor liver organoid...
migration. Clinically, on the basis of gene expression analysis, ApoE has been identified as a potential tumor-associated marker in GC9,43. In particular, ApoE was closely correlated with metastasis44. Here we clarified that ApoE was primarily expressed in TAMs and tumor cells adjacent to TAMs ...
Furthermore, portal hypertension, Child–Pugh grade B liver function, AFP > 400 ng/mL, tumor size > 5 cm, intraoperative blood transfusion, moderate/severe cirrhosis, microvascular invasion, and moderate/poor tumor differentiation were associated with worse OS (Table 4). These significant...